{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:39:33Z","timestamp":1775151573585,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The development of a preventative HIV\/AIDS vaccine is challenging due to the diversity of viral genome sequences, especially in the viral envelope (Env<jats:sub>160<\/jats:sub>). Since it is not possible to directly match the vaccine strain to the vast number of circulating HIV-1 strains, it is necessary to develop an HIV-1 vaccine that can protect against a heterologous viral challenge. Previous studies from our group demonstrated that a mixture of wild type clade B Env<jats:sub>gp160s<\/jats:sub>were able to protect against a heterologous clade B challenge more effectively than a consensus clade B Env<jats:sub>gp160<\/jats:sub>vaccine. In order to broaden the immune response to other clades of HIV, in this study rhesus macaques were vaccinated with a polyvalent mixture of purified HIV-1 trimerized consensus Env<jats:sub>gp140<\/jats:sub>proteins representing clades A, B, C, and E. The elicited immune responses were compared to a single consensus Env<jats:sub>gp140<\/jats:sub>representing all isolates in group M (Con M). Both vaccines elicited anti- Env<jats:sub>gp140<\/jats:sub>IgG antibodies that bound an equal number of HIV-1 Env<jats:sub>gp160<\/jats:sub>proteins representing clades A, B and C. In addition, both vaccines elicited antibodies that neutralized the HIV-1<jats:sub>SF162<\/jats:sub>isolate. However, the vaccinated monkeys were not protected against SHIV<jats:sub>SF162p4<\/jats:sub>challenge. These results indicate that consensus Env<jats:sub>gp160<\/jats:sub>vaccines, administered as purified Env<jats:sub>gp140<\/jats:sub>trimers, elicit antibodies that bind to Env<jats:sub>gp160s<\/jats:sub>from strains representing multiple clades of HIV-1, but these vaccines did not protect against heterologous SHIV challenge.<\/jats:p>","DOI":"10.1186\/1743-422x-10-102","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T06:14:32Z","timestamp":1364883272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge"],"prefix":"10.1186","volume":"10","author":[{"given":"Hermancia S","family":"Eugene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke R","family":"Pierce-Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jodi K","family":"Craigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted M","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,2]]},"reference":[{"issue":"3","key":"2107_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.molmed.2011.12.001","volume":"18","author":"J Hemelaar","year":"2012","unstructured":"Hemelaar J: The origin and diversity of the HIV-1 pandemic. Trends Mol Med 2012,18(3):182-192. 10.1016\/j.molmed.2011.12.001","journal-title":"Trends Mol Med"},{"key":"2107_CR2","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1126\/science.1070441","volume":"296","author":"B Gaschen","year":"2002","unstructured":"Gaschen B, Taylor J, Yusim K, Foley B, Gao F, Lang D, Novitsky V, Haynes B, Hahn BH, Bhattacharya T: Diversity Considerations in HIV-1 Vaccine Selection. Science (New York, NY) 2002, 296: 2354-2360. 10.1126\/science.1070441","journal-title":"Science (New York, NY)"},{"issue":"2","key":"2107_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/jac\/dkg079","volume":"51","author":"S Spira","year":"2003","unstructured":"Spira S, Wainberg MA, Loemba H, Turner D, Brenner BG: Impact of clade diversity on HIV-1 virulence, antiretroviral drug sensitivity and drug resistance. J Antimicrob Chemother 2003,51(2):229-240. 10.1093\/jac\/dkg079","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"2107_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1586\/14760584.7.9.1405","volume":"7","author":"SP McBurney","year":"2008","unstructured":"McBurney SP, Ross TM: Viral sequence diversity: challenges for AIDS vaccine designs. Expert Rev Vaccines 2008,7(9):1405-1417. 10.1586\/14760584.7.9.1405","journal-title":"Expert Rev Vaccines"},{"issue":"8","key":"2107_CR5","doi-asserted-by":"publisher","first-page":"622","DOI":"10.2174\/157016210794088290","volume":"8","author":"S Lu","year":"2010","unstructured":"Lu S, Grimes Serrano JM, Wang S: Polyvalent AIDS Vaccines. Curr HIV Res 2010,8(8):622-629. 10.2174\/157016210794088290","journal-title":"Curr HIV Res"},{"issue":"8","key":"2107_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.2174\/157016210794088263","volume":"8","author":"M Arenas","year":"2010","unstructured":"Arenas M, Posada D: Computational Design of Centralized HIV-1 Genes. Curr HIV Res 2010,8(8):613-621. 10.2174\/157016210794088263","journal-title":"Curr HIV Res"},{"issue":"6","key":"2107_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/157016207782418498","volume":"5","author":"F Gao","year":"2007","unstructured":"Gao F, Liao H-X, Hahn BH, Letvin NL, Korber BT, Haynes BF: Centralized HIV-1 Envelope Immunogens and Neutralizing Antibodies. Curr HIV Res 2007,5(6):572-577. 10.2174\/157016207782418498","journal-title":"Curr HIV Res"},{"key":"2107_CR8","volume-title":"AIDS Res Hum Retroviruses","author":"LG McBurney SP","year":"2012","unstructured":"McBurney SP LG, Forthal DN, Ross TM: Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent clade B virus-like particle vaccine. AIDS Res Hum Retroviruses 2012. in Press"},{"issue":"8","key":"2107_CR9","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.vaccine.2007.12.024","volume":"26","author":"S Wang","year":"2008","unstructured":"Wang S, Kennedy JS, West K, Montefiori DC, Coley S, Lawrence J, Shen S, Green S, Rothman AL, Ennis FA: Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime\u00e2\u20ac\u201cprotein boost HIV-1 vaccine in healthy human volunteers. Vaccine 2008,26(8):1098-1110. 10.1016\/j.vaccine.2007.12.024","journal-title":"Vaccine"},{"issue":"7","key":"2107_CR10","doi-asserted-by":"publisher","first-page":"e22010","DOI":"10.1371\/journal.pone.0022010","volume":"6","author":"SK Lakhashe","year":"2011","unstructured":"Lakhashe SK, Wang W, Siddappa NB, Hemashettar G, Polacino P, Hu SL, Villinger F, Else JG, Novembre FJ, Yoon JK: Vaccination against Heterologous R5 Clade C SHIV: Prevention of Infection and Correlates of Protection. PLoS One 2011,6(7):e22010. 10.1371\/journal.pone.0022010","journal-title":"PLoS One"},{"issue":"2","key":"2107_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/sj.mt.6300036","volume":"15","author":"J Yan","year":"2007","unstructured":"Yan J, Yoon H, Kumar S, Ramanathan MP, Corbitt N, Kutzler M, Dai A, Boyer JD, Weiner DB: Enhanced Cellular Immune Responses Elicited by an Engineered HIV-1 Subtype B Consensus-based Envelope DNA Vaccine. Mol Ther 2007,15(2):411-421. 10.1038\/sj.mt.6300036","journal-title":"Mol Ther"},{"issue":"32","key":"2107_CR12","doi-asserted-by":"publisher","first-page":"4337","DOI":"10.1016\/j.vaccine.2009.04.032","volume":"27","author":"SP McBurney","year":"2009","unstructured":"McBurney SP, Ross TM: Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine 2009,27(32):4337-4349. 10.1016\/j.vaccine.2009.04.032","journal-title":"Vaccine"},{"issue":"30","key":"2107_CR13","doi-asserted-by":"publisher","first-page":"10489","DOI":"10.1073\/pnas.0803352105","volume":"105","author":"S Santra","year":"2008","unstructured":"Santra S, Korber BT, Muldoon M, Barouch DH, Nabel GJ, Gao F, Hahn BH, Haynes BF, Letvin NL: A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys. PNAS 2008,105(30):10489-10494. 10.1073\/pnas.0803352105","journal-title":"PNAS"},{"issue":"2","key":"2107_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.virol.2006.04.043","volume":"353","author":"H-X Liao","year":"2006","unstructured":"Liao H-X, Sutherland LL, Xia S-M, Brock ME, Scearce RM, Vanleeuwen S, Alam SM, McAdams M, Weaver EA, Camacho ZT: A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses. Virology 2006,353(2):268-282. 10.1016\/j.virol.2006.04.043","journal-title":"Virology"},{"issue":"26","key":"2107_CR15","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1016\/j.vaccine.2006.03.063","volume":"24","author":"JF Bower","year":"2006","unstructured":"Bower JF, Li Y, Wyatt R, Ross TM: HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Vaccine 2006,24(26):5442-5451. 10.1016\/j.vaccine.2006.03.063","journal-title":"Vaccine"},{"issue":"10","key":"2107_CR16","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/protein\/gzh085","volume":"17","author":"R Pantophlet","year":"2004","unstructured":"Pantophlet R, Wilson IA, Burton DR: Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12. PEDS 2004,17(10):749-758.","journal-title":"PEDS"},{"issue":"3","key":"2107_CR17","doi-asserted-by":"publisher","first-page":"e18207","DOI":"10.1371\/journal.pone.0018207","volume":"6","author":"JD Watkins","year":"2011","unstructured":"Watkins JD, Siddappa NB, Lakhashe SK, Humbert M, Sholukh A, Hemashettar G, Wong YL, Yoon JK, Wang W, Novembre FJ: An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV. PLoS One 2011,6(3):e18207. 10.1371\/journal.pone.0018207","journal-title":"PLoS One"},{"issue":"3","key":"2107_CR18","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/QAD.0b013e3282f3ca57","volume":"22","author":"SW Barnett","year":"2008","unstructured":"Barnett SW, Srivastava IK, Kan E, Zhou F, Goodsell A, Cristillo AD, Ferrai MG, Weiss DE, Letvin NL, Montefiori D: Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS 2008,22(3):339-348. 10.1097\/QAD.0b013e3282f3ca57","journal-title":"AIDS"},{"issue":"12","key":"2107_CR19","doi-asserted-by":"publisher","first-page":"5975","DOI":"10.1128\/JVI.02533-09","volume":"84","author":"SW Barnett","year":"2010","unstructured":"Barnett SW, Burke B, Sun Y, Kan E, Legg H, Lian Y, Bost K, Zhou F, Goodsell A, zur Megede J: Antibody-Mediated Protection against Mucosal Simian-Human Immunodeficiency Virus Challenge of Macaques Immunized with Alphavirus Replicon Particles and Boosted with Trimeric Envelope Glycoprotein in MF59 Adjuvant. J Virol 2010,84(12):5975-5985. 10.1128\/JVI.02533-09","journal-title":"J Virol"},{"issue":"1","key":"2107_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.virol.2006.10.017","volume":"360","author":"DL Kothe","year":"2007","unstructured":"Kothe DL, Decker JM, Li Y, Weng Z, Bibollet-Ruche F, Zammit KP, Salazar MG, Chen Y, Salazar-Gonzalez JF, Moldoveanu Z: Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins. Virology 2007,360(1):218-234. 10.1016\/j.virol.2006.10.017","journal-title":"Virology"},{"issue":"2","key":"2107_CR21","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.virol.2006.05.011","volume":"352","author":"DL Kothe","year":"2006","unstructured":"Kothe DL, Li Y, Decker JM, Bibollet-Ruche F, Zammit KP, Salazar MG, Chen Y, Weng Z, Weaver EA, Gao F: Ancestral and consensus envelope immunogens for HIV-1 subtype C. Virology 2006,352(2):438-449. 10.1016\/j.virol.2006.05.011","journal-title":"Virology"},{"key":"2107_CR22","volume-title":"Nature","author":"DH Barouch","year":"2012","unstructured":"Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G: Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature 2012. advance online publication"},{"issue":"1","key":"2107_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.virol.2006.04.030","volume":"352","author":"VA Sharma","year":"2006","unstructured":"Sharma VA, Kan E, Sun Y, Lian Y, Cisto J, Frasca V, Hilt S, Stamatatos L, Donnelly JJ, Ulmer JB: Structural characteristics correlate with immune responses induced by HIV envelope glycoprotein vaccines. Virology 2006,352(1):131-144. 10.1016\/j.virol.2006.04.030","journal-title":"Virology"},{"key":"2107_CR24","doi-asserted-by":"publisher","first-page":"11440","DOI":"10.1073\/pnas.1101414108","volume":"108","author":"A Harris","year":"2011","unstructured":"Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang Y, Depetris R, Marozsan AJ, Sanders RW: Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures. Proc Natl Acad Sci U S A 2011, 108: 11440-11445. 10.1073\/pnas.1101414108","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5532","key":"2107_CR25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1126\/science.1061692","volume":"293","author":"EO Saphire","year":"2001","unstructured":"Saphire EO, Parren PWHI, Pantophlet R, Zwick MB, Morris GM, Rudd PM, Dwek RA, Stanfield RL, Burton DR, Wilson IA: Crystal Structure of a Neutralizing Human IgG Against HIV-1: A Template for Vaccine Design. Science 2001,293(5532):1155-1159. 10.1126\/science.1061692","journal-title":"Science"},{"key":"2107_CR26","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3390\/v1031265","volume":"1","author":"V Holl","year":"2009","unstructured":"Holl V, Peressin M, Moog C: Antibody-Mediated Fc\u03c8 Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies. Viruses 2009, 1: 1265-1294. 10.3390\/v1031265","journal-title":"Viruses"},{"issue":"9","key":"2107_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nri891","volume":"2","author":"DR Burton","year":"2002","unstructured":"Burton DR: Antibodies, viruses and vaccines. Nat Rev Immunol 2002,2(9):706-713. 10.1038\/nri891","journal-title":"Nat Rev Immunol"},{"issue":"14)","key":"2107_CR28","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R, Liao HX: Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N Engl J Med 2012,366(14)):1275-86.","journal-title":"N Engl J Med"},{"key":"2107_CR29","unstructured":"Barouch DH, Liu J, Li H, Maxfield LF, Abbink P, Lynch DM, Iampietro MJ, SanMiguel A, Seaman MS, Ferrari G: Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys. Nature advance online publication"},{"key":"2107_CR30","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","volume":"361","author":"S Rerks-Ngarm","year":"2009","unstructured":"Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E: Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N Eng J Med 2009, 361: 2209-2220. 10.1056\/NEJMoa0908492","journal-title":"N Eng J Med"},{"issue":"14","key":"2107_CR31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1056\/NEJMoa1113425","volume":"366","author":"BF Haynes","year":"2012","unstructured":"Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, Evans DT, Montefiori DC, Karnasuta C, Sutthent R: Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial. N Eng J Med 2012,366(14):1275-1286. 10.1056\/NEJMoa1113425","journal-title":"N Eng J Med"},{"key":"2107_CR32","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1128\/JVI.01272-09","volume":"84","author":"AJ Hessell","year":"2009","unstructured":"Hessell AJ, Rakasz EG, Tehrani DM, Huber M, Weisgrau KL, Landucci G, Forthal DN, Koff WC, Poignard P, Watkins DI: Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L. J Virol 2009, 84: 1302-1313.","journal-title":"J Virol"},{"issue":"3","key":"2107_CR33","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/QAD.0b013e3282f3ca57","volume":"22","author":"SW Barnett","year":"2008","unstructured":"Barnett SW, Srivastava IK, Kan E, Zhou F, Goodsell A, Cristillo AD, Ferrai MG, Weiss DE, Letvin NL, Montefiori D: Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope. AIDS 2008,22(3):339-348. 10.1097\/QAD.0b013e3282f3ca57","journal-title":"AIDS"},{"key":"2107_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11904-011-0108-2","volume":"9","author":"M Smith","year":"2012","unstructured":"Smith M, Wightman F, Lewin S: HIV Reservoirs and strategies for eradication. Curr HIV\/AIDS Rep 2012, 9: 5-15. 10.1007\/s11904-011-0108-2","journal-title":"Curr HIV\/AIDS Rep"},{"key":"2107_CR35","doi-asserted-by":"publisher","first-page":"5618","DOI":"10.1128\/JVI.02748-07","volume":"82","author":"RS Veazey","year":"2008","unstructured":"Veazey RS, Acierno PM, McEvers KJ, Baumeister SHC, Foster GJ, Rett MD, Newberg MH, Kuroda MJ, Williams K, Kim E-Y: Increased Loss of CCR5+ CD45RA\u00e2\u02c6\u2019 CD4+ T Cells in CD8+ Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys. J Virol 2008, 82: 5618-5630. 10.1128\/JVI.02748-07","journal-title":"J Virol"},{"key":"2107_CR36","doi-asserted-by":"publisher","first-page":"8827","DOI":"10.1128\/JVI.00895-07","volume":"81","author":"JT Loffredo","year":"2007","unstructured":"Loffredo JT, Maxwell J, Qi Y, Glidden CE, Borchardt GJ, Soma T, Bean AT, Beal DR, Wilson NA, Rehrauer WM: Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication. J Virol 2007, 81: 8827-8832. 10.1128\/JVI.00895-07","journal-title":"J Virol"},{"issue":"34","key":"2107_CR37","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1016\/j.vaccine.2011.06.017","volume":"29","author":"SK Lakhashe","year":"2011","unstructured":"Lakhashe SK, Velu V, Siddappa NB, Dipasquale JM, Hemashettar G, Yoon JK, Rasmussen RA, Yang F, Lee SJ, Montefiori DC: Prime-boost vaccination with heterologous live vectors encoding SIV gag and multimeric HIV-1 gp160 protein: efficacy against repeated mucosal R5 clade C SHIV challenges. Vaccine 2011,29(34):5611-24. 10.1016\/j.vaccine.2011.06.017","journal-title":"Vaccine"},{"issue":"9","key":"2107_CR38","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1084\/jem.20100025","volume":"207","author":"C Sundling","year":"2010","unstructured":"Sundling C, Forsell MN, O'Dell S, Feng Y, Chakrabarti B, Rao SS, Lor\u00e9 K, Mascola JR, Wyatt RT, Douagi I: Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates. J Exp Med 2010,207(9):2003-2017. 10.1084\/jem.20100025","journal-title":"J Exp Med"},{"issue":"43","key":"2107_CR39","doi-asserted-by":"publisher","first-page":"7016","DOI":"10.1016\/j.vaccine.2010.08.035","volume":"28","author":"I Leroux-Roels","year":"2010","unstructured":"Leroux-Roels I, Koutsoukos M, Clement F, Steyaert S, Janssens M, Bourguignon P, Cohen K, Altfeld M, Vandepapeli\u00e8re P, Pedneault L: Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems. Vaccine 2010,28(43):7016-7024. 10.1016\/j.vaccine.2010.08.035","journal-title":"Vaccine"},{"issue":"5","key":"2107_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.vaccine.2007.11.040","volume":"26","author":"R Gavioli","year":"2008","unstructured":"Gavioli R, Cellini S, Castaldello A, Voltan R, Gallerani E, Gagliardoni F, Fortini C, Cofano EB, Triulzi C, Cafaro A: The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS. Vaccine 2008,26(5):727-737. 10.1016\/j.vaccine.2007.11.040","journal-title":"Vaccine"},{"issue":"16","key":"2107_CR41","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1016\/j.vaccine.2011.02.006","volume":"29","author":"F Ferrantelli","year":"2011","unstructured":"Ferrantelli F, Maggiorella MT, Schiavoni I, Sernicola L, Olivieri E, Farcomeni S, Pavone-Cossut MR, Moretti S, Belli R, Collacchi B: A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study. Vaccine 2011,29(16):2918-2932. 10.1016\/j.vaccine.2011.02.006","journal-title":"Vaccine"},{"issue":"19","key":"2107_CR42","doi-asserted-by":"publisher","first-page":"10354","DOI":"10.1128\/JVI.00803-10","volume":"84","author":"AL Ferre","year":"2010","unstructured":"Ferre AL, Lemongello D, Hunt PW, Morris MM, Garcia JC, Pollard RB, Yee HF, Martin JN, Deeks SG, Shacklett BL: Immunodominant HIV-Specific CD8+ T-Cell Responses Are Common to Blood and Gastrointestinal Mucosa, and Gag-Specific Responses Dominate in Rectal Mucosa of HIV Controllers. J Virol 2010,84(19):10354-10365. 10.1128\/JVI.00803-10","journal-title":"J Virol"},{"issue":"1","key":"2107_CR43","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1128\/JVI.05577-11","volume":"86","author":"S Ranasinghe","year":"2011","unstructured":"Ranasinghe S, Flanders M, Cutler S, Soghoian DZ, Ghebremichael M, Davis I, Lindqvist M, Pereyra F, Walker BD, Heckerman D: HIV-Specific CD4 T Cell Responses to Different Viral Proteins Have Discordant Associations with Viral Load and Clinical Outcome. J Virol 2011,86(1):277-283.","journal-title":"J Virol"},{"issue":"1","key":"2107_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.imlet.2009.12.022","volume":"129","author":"FR Toapanta","year":"2010","unstructured":"Toapanta FR, DeAlmeida DR, Dunn MD, Ross TM: C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2. Immunol Lett 2010,129(1):32-38. 10.1016\/j.imlet.2009.12.022","journal-title":"Immunol Lett"},{"key":"2107_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/0-387-34134-X_17","volume-title":"Current Topics in Complement vol. 586","author":"JF Bower","year":"2006","unstructured":"Bower JF, Ross TM: A Minimum CR2 Binding Domain of C3d Enhances Immunity Following Vaccination. In Current Topics in Complement vol. 586. Edited by: Lambris JD. US: Springer; 2006:249-264."},{"issue":"2","key":"2107_CR46","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.virol.2004.07.009","volume":"327","author":"KR Young","year":"2004","unstructured":"Young KR, Smith JM, Ross TM: Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle. Virology 2004,327(2):262-272. 10.1016\/j.virol.2004.07.009","journal-title":"Virology"},{"issue":"19","key":"2107_CR47","doi-asserted-by":"publisher","first-page":"12311","DOI":"10.1128\/JVI.79.19.12311-12320.2005","volume":"79","author":"JD Steckbeck","year":"2005","unstructured":"Steckbeck JD, Orlov I, Chow A, Grieser H, Miller K, Bruno J, Robinson JE, Montelaro RC, Cole KS: Kinetic Rates of Antibody Binding Correlate with Neutralization Sensitivity of Variant Simian Immunodeficiency Virus Strains. J Virol 2005,79(19):12311-12320. 10.1128\/JVI.79.19.12311-12320.2005","journal-title":"J Virol"},{"issue":"7","key":"2107_CR48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1086\/507306","volume":"194","author":"S Subbarao","year":"2006","unstructured":"Subbarao S, Otten RA, Ramos A, Kim C, Jackson E, Monsour M, Adams DR, Bashirian S, Johnson J, Soriano V: Chemoprophylaxis with Tenofovir Disoproxil Fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis 2006,194(7):904-911. 10.1086\/507306","journal-title":"J Infect Dis"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-102.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T20:30:25Z","timestamp":1644697825000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2107"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-102","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,2]]},"assertion":[{"value":"12 September 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"102"}}